Table 1.
Participants characteristics
| Variable | Total, n (%) (N=840) | HIV-infected, n (%) (n=176) | HIV-uninfected, n (%) (n=664) | p |
|---|---|---|---|---|
| Age ≤5 years | 202 (24.05) | 46 (26.14) | 156 (23.49) | 0.5286 |
| Mean age ± SD (years) | 8.27±3.95 | 8.30±3.92 | 8.16±4.08 | 0.6767 |
| Male sex | 438 (52.14) | 89 (50.57) | 349 (52.56) | 0.6998 |
| Absence of BGC vaccine scar | 120 (14.29) | 22 (12.50) | 98 (14.76) | 0.5219 |
| History of contact with a smear-positive TB patient | 595 (70.83) | 128 (72.73) | 467 (70.33) | 0.5971 |
| Re-treatment | 57 (6.79) | 36 (20.45) | 21 (3.16) | <0.00001 |
| Fever ≥2 weeks | 615 (73.21) | 140 (79.55) | 475 (71.54) | 0.0415 |
| Cough ≥2 weeks | 463 (55.12) | 99 (56.25) | 364 (54.82) | 0.7994 |
| Lymphadenopathy | 380 (45.24) | 79 (44.89) | 301 (45.33) | 0.9838 |
| Anorexia | 580 (69.05) | 124 (70.45) | 456 (68.67) | 0.7170 |
| Weight loss | 547 (65.12) | 123 (69.89) | 424 (63.86) | 0.1604 |
| Night sweats | 376 (44.76) | 72 (40.91) | 304 (45.78) | 0.2842 |
| Poor nutritional status (WAZ ≤ -2 SD) | 205 (24.40) | 80 (45.45) | 125 (18.83) | <0.00001 |
| EPTB | 123 (14.64) | 37 (21.02) | 86 (12.95) | 0.0100 |
| TST positive | 533 (63.45) | 100 (56.82) | 433 (65.21) | 0.0399 |
| AFB positive | 201 (28.03) | 34 (24.46) | 167 (28.89) | 0.3475 |
HIV: human immunodeficiency virus; SD: standard deviation; TB: tuberculosis; TST: Tuberculin skin test; AFB: Acid Fast Bacilli; WAZ: Weight-for-Age Z-score; EPTB: Extra pulmonary tuberculosis